In a report issued on January 24, Peter Arment from Robert W. Baird maintained a Buy rating on Maxar Technologies (MAXR – Research Report), with a price target of $39.00. The company’s shares closed last Thursday at $27.36, close to its 52-week low of $22.92.
According to TipRanks.com, Arment is a 5-star analyst with an average return of 11.0% and a 63.1% success rate. Arment covers the Technology sector, focusing on stocks such as L3Harris Technologies, Raytheon Technologies, and Spirit AeroSystems.
Currently, the analyst consensus on Maxar Technologies is a Moderate Buy with an average price target of $37.67, a 38.4% upside from current levels. In a report issued on January 20, RBC Capital also initiated coverage with a Buy rating on the stock with a $42.00 price target.
Based on Maxar Technologies’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $437 million and net profit of $14 million. In comparison, last year the company earned revenue of $436 million and had a net profit of $85 million.
Based on the recent corporate insider activity of 129 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MAXR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Maxar Technologies, Inc. provides space technology solutions, delivering unmatched end-to-end capabilities in satellites, robotics, Earth imagery, geospatial data, analytics and insights. Its segments include Space Systems, Imagery and Services. The company was founded on February 3, 1969 and is headquartered in Westminster, Co.
Read More on MAXR:
- Leerink Partners Thinks Vericel’s Stock is Going to Recover
- Leerink Partners Thinks Silk Road Medical’s Stock is Going to Recover
- Boston Scientific (BSX) Receives a Hold from Leerink Partners
- Outset Medical (OM) Gets a Buy Rating from Leerink Partners
- Mercury Systems (MRCY) Receives a Hold from Robert W. Baird